Because multi-drug resistance (MDR) is an essential aspect of human lung cancer chemotherapy failure [30], effectively reducing the expression of the MDR1 gene can increase patients’ sensitivity to chemotherapy drugs. The gene discussed is ABCB1; the disease is lung carcinoma.